| Literature DB >> 28951302 |
Ziqie Rao1, Hongyu Ge1, Liangling Liu1, Chen Zhu1, Lian Min1, Meng Liu1, Lihong Fan2, Dan Li3.
Abstract
Nanotechnology has been studied to improve drug delivery and cancer treatment. The aim of this study is to introduce amino groups into graphene oxide (GO) to form aminated fumed graphene (GO-ADH) and combine GO-ADH with carboxymethyl cellulose (CMC) to produce GO-CMC complex as a drug carrier matrix. The anti-cancer drug small molecule doxorubicin hydrochloride (DOX) was bond to GO-CMC by π-π bond interaction and hydrogen bonding to form GO-CMC/DOX drug loading system. Via the FT-IR, transmission electron microscopy (TEM) and Zeta potential analyzer analysis showed that GO-CMC complex was successfully synthesized. Studies have shown that when pH=5.0, the cumulative release rate of drugs can reach 65.2%, which means it has pH-sensitive ability. The cells were treated with MTT method and human cervical cancer cells (Hela cells) and mouse fibroblasts (NIH-3T3 cells). The results showed that GO-CMC had no obvious cytotoxicity and good biocompatibility.Entities:
Keywords: Carboxymethyl cellulose; Controlled release; Doxorubicin hydrochloride; Drug delivery; Graphene oxide
Mesh:
Substances:
Year: 2017 PMID: 28951302 DOI: 10.1016/j.ijbiomac.2017.09.096
Source DB: PubMed Journal: Int J Biol Macromol ISSN: 0141-8130 Impact factor: 6.953